AstraZeneca has decided to halt its £200 million investment plan at its research center in Cambridge, a project that would have created approximately 1,000 jobs. This is the company's second major withdrawal from the UK in 2024, after it abandoned a £450 million investment in vaccine manufacturing in January. The decisions of pharmaceutical companies, including Merck & Co., are putting pressure on the British government in the context of maintaining attractiveness for investments in the pharmaceutical sector.
Sources
AstraZeneca suspendă o investiţie de 270 de milioane de dolari în Marea Britanie
Britain’s biggest company AstraZeneca pauses £200m investment into Cambridge site
AstraZeneca pauses £200m Cambridge investment
Britain’s biggest company AstraZeneca pauses £200m investment into Cambridge site
Latest News
18:54
DIICOT detained two men from Timiș County accused of selling cocaine and cannabis worth more than 2.7 million lei
18:48
Elon Musk argues that Russian soldiers sent to Ukraine deserve more compassion
18:40
UE ajunge la un acord pentru amânarea cu doi ani a obligațiilor privind metanul din importurile de gaze, petrol și cărbune
18:38
Health Minister Alexandru Rogobete discusses new measures for hospitals and medicine stocks with NATO
18:31
The Chamber of Tax Consultants warns: ANAF’s new rules for VAT refunds could block investments
See more news